Princeton, NJ (PRWEB) January 18, 2013
NovoPath, Inc., a leader in Anatomic Pathology (AP) Best-of-Breed Software Solutions, will provide ongoing educational opportunities, on booth #1317 at the 2013 US & Canadian Academy of Pathology (USCAP) annual meeting in Baltimore, March 2 through 6.
Pathologists and Lab Managers are invited to learn more about NovoPath’s AP-focused Laboratory Information System, refined over 15 years with direct pathologist input. This fully intuitive system is robust, scalable, and modular – making it the right AP LIS for the subspecialty through national reference lab, and community hospital to medical center. The NovoPath AP LIS offers optional EMR connectivity to support Meaningful Use, and seamlessly integrates with lab and enterprise-wide systems.
While visiting the NovoPath exhibit, laboratory personnel will have an opportunity to view their featured product – NovoNotifier Mobile; the first Smartphone app for Android and Apple that provides secure, on-the-go, full-length AP report access. Clinicians now have immediate mobile access and can view AP reports in their entirety, anytime and anyplace – in the 100% identical customized format developed by their pathology lab.
Additional opportunities to view NovoPath’s AP LIS in action include the following professional meetings: Clinical Laboratory Management Association (CLMA) in Orlando on April 6-8, Advances in Cytology in Boston June 9-13, the Association for Pathology Informatics (APIII) in Pittsburgh September 17-18, the American Society of Clinical Pathology (ASCP) in Chicago September 17-19, the College of American Pathologists (CAP'13) in Orlando October 11-14, and the Association of Molecular Pathology (AMP) in Phoenix November 13-15.
Rick Callahan, VP of Sales and Marketing, offered, “To make certain your staff receives the individual attention they deserve, we encourage you to make a booth appointment for a personal demonstration of the NovoPath AP LIS. Please contact me at 877.668.6123 or RCallahan(at)NovoPath(dot)com to confirm your appointment at the USCAP, or any of these meetings.”
About NovoPath, Inc.:
NovoPath, Inc. develops and markets software solutions for the Anatomic Pathology Laboratory market segment that includes local, regional, national, in-house laboratories as well as community and university teaching hospitals and medical centers. Since the release of its flagship product in 1999, NovoPath, Inc. has focused exclusively on Anatomic Pathology. NovoPath's mission is to provide unique and unparalleled solutions and services to all aspects of the Anatomic Pathology sector in a way that improves workflow, reduces the probability of human error, ensures results accuracy for greater patient safety, protects patient confidentiality, and above all, produces more precise and informative diagnostic outcomes. More information is available at http://www.NovoPath.com.